You are here: Home » Economy & Policy » News
Business Standard

Govt should notify e-pharmacy rules as uncertainty dampens growth: Experts

The government should finalise and notify e-pharmacy rules immediately as the regulatory uncertainty dampens growth and new investment in the sector, according to the experts.

Topics
E-Pharma

Press Trust of India  |  New Delhi 

pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing

The government should finalise and notify e-pharmacy rules immediately as the regulatory uncertainty dampens growth and new investment in the sector, according to the experts.

Panellists on the discussion also said there remains ambiguity on the legality of marketplaces.

They were participating in a discussion on 'e-Pharmacy: Digitally Empowering Consumers & Small Businesses' organised by the Internet and Mobile Association of India (IAMAI).

"We must notify the rules which are catching dust within the ministry at the earliest opportunity... All e-pharmacies are governed by law and governed by the manner which is being spelt out in the law," Patients Safety and Access Founder Director Bejon Misra said.

The notification is pending and it should come out as soon as possible, he added.

"We must encourage healthy competition at the marketplace and we must encourage ethical players, we must recognise them," Misra said.

In a similar vein, 1mg Chief Operating Officer Tanmay Saksena said: "Our model is completely compliant under a combination of various regulations that already exist, what we are really requesting and hoping is that there will be harmonisation of all the regulations under one common aegis."

E-pharmacies are already operating under pre-defined regulations. We are subject to the Drugs and Cosmetics Act. We are purely platforms linking consumers to the pharmacies that already exist in the ecosystem and have introduced better trackability and traceability, he added.

The retail pharmacy sector needs a lot of supply chain, technology and access solutions to make healthcare delivery more efficient and affordable, and a prerequisite for this is a simple and clear regulatory pathway for innovation to thrive in this important space, IAMAI said in a statement.

It also expressed hope that the issues being faced by the e-Pharmacy sector will now be addressed through a quick notification of the pending e-Pharmacy draft rules, it added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, October 14 2020. 20:37 IST
RECOMMENDED FOR YOU
.